Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Histamine ameliorates anti-glomerular basement membrane antibody-induced glomerulonephritis in rats.

Tanda S, Mori Y, Kimura T, Sonomura K, Kusaba T, Kishimoto N, Kameyama H, Tamagaki K, Okigaki M, Hatta T, Sasaki S, Takeda K, Sado Y, Adachi N, Matsubara H.

Kidney Int. 2007 Sep;72(5):608-13. Epub 2007 Jun 13.

2.

Blockade of the c-Jun amino terminal kinase prevents crescent formation and halts established anti-GBM glomerulonephritis in the rat.

Ma FY, Flanc RS, Tesch GH, Bennett BL, Friedman GC, Nikolic-Paterson DJ.

Lab Invest. 2009 Apr;89(4):470-84. doi: 10.1038/labinvest.2009.2. Epub 2009 Feb 2.

3.

Pentoxifylline suppresses renal tumour necrosis factor-alpha and ameliorates experimental crescentic glomerulonephritis in rats.

Chen YM, Ng YY, Lin SL, Chiang WC, Lan HY, Tsai TJ.

Nephrol Dial Transplant. 2004 May;19(5):1106-15. Epub 2004 Feb 19.

PMID:
14993492
4.

Prevention of glomerular crescent formation in glomerulonephritis by mycophenolate mofetil in rats.

Takeda S, Takahashi M, Sado Y, Takeuchi K, Hakamata Y, Shimizu H, Kaneko T, Yamamoto H, Ito C, Ookawara S, Asano Y, Kusano E, Kobayashi E.

Nephrol Dial Transplant. 2004 Sep;19(9):2228-36. Epub 2004 Jul 6.

PMID:
15238626
5.

Antibodies to intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 prevent crescent formation in rat autoimmune glomerulonephritis.

Nishikawa K, Guo YJ, Miyasaka M, Tamatani T, Collins AB, Sy MS, McCluskey RT, Andres G.

J Exp Med. 1993 Mar 1;177(3):667-77.

6.

Suppression of experimental crescentic glomerulonephritis by interleukin-10 gene transfer.

El-Shemi AG, Fujinaka H, Matsuki A, Kamiie J, Kovalenko P, Qu Z, Bilim V, Nishimoto G, Yaoita E, Yoshida Y, Anegon I, Yamamoto T.

Kidney Int. 2004 Apr;65(4):1280-9.

7.

Therapeutic effect of all-trans retinoic acid on rats with anti-GBM antibody glomerulonephritis.

Oseto S, Moriyama T, Kawada N, Nagatoya K, Takeji M, Ando A, Yamamoto T, Imai E, Hori M.

Kidney Int. 2003 Oct;64(4):1241-52.

8.
9.

Fc receptor-mediated accumulation of macrophages in crescentic glomerulonephritis induced by anti-glomerular basement membrane antibody administration in WKY rats.

Kovalenko P, Fujinaka H, Yoshida Y, Kawamura H, Qu Z, El-Shemi AG, Li H, Matsuki A, Bilim V, Yaoita E, Abo T, Uchiyama M, Yamamoto T.

Int Immunol. 2004 May;16(5):625-34. Epub 2004 Apr 5.

PMID:
15096492
10.

Effects of CTLA4-Fc on glomerular injury in humorally-mediated glomerulonephritis in BALB/c mice.

Kitching AR, Huang XR, Ruth AJ, Tipping PG, Holdsworth SR.

Clin Exp Immunol. 2002 Jun;128(3):429-35.

11.

Immune modulation with interleukin-4 and interleukin-10 prevents crescent formation and glomerular injury in experimental glomerulonephritis.

Tipping PG, Kitching AR, Huang XR, Mutch DA, Holdsworth SR.

Eur J Immunol. 1997 Feb;27(2):530-7.

PMID:
9045927
12.

Statin attenuates experimental anti-glomerular basement membrane glomerulonephritis together with the augmentation of alternatively activated macrophages.

Fujita E, Shimizu A, Masuda Y, Kuwahara N, Arai T, Nagasaka S, Aki K, Mii A, Natori Y, Iino Y, Katayama Y, Fukuda Y.

Am J Pathol. 2010 Sep;177(3):1143-54. doi: 10.2353/ajpath.2010.090608. Epub 2010 Aug 9.

13.

Preventive effect of sulphated colominic acid on P-selectin-dependent infiltration of macrophages in experimentally induced crescentic glomerulonephritis.

Ogawa D, Shikata K, Matsuda M, Okada S, Wada J, Yamaguchi S, Suzuki Y, Miyasaka M, Tojo S, Makino H.

Clin Exp Immunol. 2002 Jul;129(1):43-53.

14.

Low-level laser therapy improves crescentic glomerulonephritis in rats.

Yamato M, Kaneda A, Kataoka Y.

Lasers Med Sci. 2013 Jul;28(4):1189-96. doi: 10.1007/s10103-012-1229-6. Epub 2012 Nov 9.

PMID:
23139073
15.

Effect of interleukin-10 treatment on crescentic glomerulonephritis in rats.

Chadban SJ, Tesch GH, Lan HY, Atkins RC, Nikolic-Paterson DJ.

Kidney Int. 1997 Jun;51(6):1809-17.

16.

Atorvastatin enhances humoral immune responses but does not alter renal injury in experimental crescentic glomerulonephritis.

Phoon RK, Kitching AR, Jones LK, Holdsworth SR.

Nephrology (Carlton). 2009 Oct;14(7):650-7. doi: 10.1111/j.1440-1797.2009.01141.x.

PMID:
19796023
18.
19.

c-fms blockade reverses glomerular macrophage infiltration and halts development of crescentic anti-GBM glomerulonephritis in the rat.

Han Y, Ma FY, Tesch GH, Manthey CL, Nikolic-Paterson DJ.

Lab Invest. 2011 Jul;91(7):978-91. doi: 10.1038/labinvest.2011.61. Epub 2011 Apr 25.

20.

ANG II receptor blockade enhances anti-inflammatory macrophages in anti-glomerular basement membrane glomerulonephritis.

Aki K, Shimizu A, Masuda Y, Kuwahara N, Arai T, Ishikawa A, Fujita E, Mii A, Natori Y, Fukunaga Y, Fukuda Y.

Am J Physiol Renal Physiol. 2010 Apr;298(4):F870-82. doi: 10.1152/ajprenal.00374.2009. Epub 2010 Jan 13.

Supplemental Content

Support Center